<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03208452</url>
  </required_header>
  <id_info>
    <org_study_id>B1605/346-002</org_study_id>
    <nct_id>NCT03208452</nct_id>
  </id_info>
  <brief_title>The Effect of Intraoperative Magnesium Sulfate Infusion on the Occurrence of Emergence Agitation</brief_title>
  <official_title>The Effect of Intraoperative Magnesium Sulfate Infusion on the Occurrence of Emergence Agitation After Pediatric Ophthalmic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study designed to evaluate the correlation between the effect of intraoperative
      magnesium sulfate infusion and the incidence of emergence agitation after pediatric
      ophthalmic surgery
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Emergence agitation (EA) is a frequent postoperative complication in pediatric patients after
      general anesthesia. There are several suggested causes of EA and pain has been considered one
      of them. Magnesium is an N-methyl-D-aspartate (NMDA) receptor antagonist and increasingly
      used as an analgesic-adjuvant. We evaluate the Pediatric Anesthesia Emergence Delirium (PAED)
      Scale to investigate whether the intraoperative infusion of magnesium sulfate reduces the
      incidence of EA in pediatric patients who undergo ophthalmic outpatient surgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 19, 2017</start_date>
  <completion_date type="Actual">December 19, 2018</completion_date>
  <primary_completion_date type="Actual">December 19, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the incidence of emergence agitation (EA)</measure>
    <time_frame>15 minute interval at the post-anesthetic care unit (PACU)</time_frame>
    <description>Using PAED (pediatric anesthesia emergence delirium) score, consider the score 10 or more as occuring of EA. Comparing the score between the placebo group and the intervention group for the difference of the incidence of EA.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the severity of EA</measure>
    <time_frame>15 minute interval at the post-anesthetic care unit (PACU)</time_frame>
    <description>Comparing the maximal PAED score between the placebo group and the intervention group for evaluating difference of severity of EA.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">92</enrollment>
  <condition>Agitation,Psychomotor</condition>
  <arm_group>
    <arm_group_label>Normal saline(NS) group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>loading 50mL of normal saline during 10minutes before starting of surgery, after starting of surgery, continuous infusion of normal saline as placebo by 0.15mg/kg/h until the end of surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Magnesium group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>loading dose of 50mg/kg magnesium sulfate during 10minutes before starting of surgery, during the surgery, continuous infusion of magnesium sulfate by 15mg/kg/h</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Magnesium Sulfate</intervention_name>
    <description>Comparing the effect of continuous infusion magnesium sulfate and normal saline in the occurrence of emergence agitation</description>
    <arm_group_label>Magnesium group</arm_group_label>
    <other_name>10% magnesium sulfate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>Comparing the effect of continuous infusion magnesium sulfate and normal saline in the occurrence of emergence agitation</description>
    <arm_group_label>Normal saline(NS) group</arm_group_label>
    <other_name>0.9% isotonic normal saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  pediatric patients who are planned to operate ophthalmic surgery under general
             anesthesia aged 4-7 years

        Exclusion Criteria:

          -  ASA class â‰¥ III

          -  imbalance of electrolyte

          -  myocardial damage or conduction abnormality on ECG

          -  myasthenia gravis or any other neuromuscular disease

          -  impaired renal function

          -  denial to participate in study or not be able to give informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>7 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>YEA JI LEE</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <zip>13620</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>June 30, 2017</study_first_submitted>
  <study_first_submitted_qc>July 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 5, 2017</study_first_posted>
  <last_update_submitted>April 6, 2020</last_update_submitted>
  <last_update_submitted_qc>April 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>LEE YEA JI</investigator_full_name>
    <investigator_title>clinical professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psychomotor Agitation</mesh_term>
    <mesh_term>Emergence Delirium</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Magnesium Sulfate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

